References
  1. Fuloria M, Aschner JL. Persistent pulmonary hypertension of the newborn. Semin Fetal Neonatal Med. 2017 Aug;22(4):220-226. doi: 10.1016/j.siny.2017.03.004. Epub 2017 Mar 23. PMID: 28342684.
  2. Konduri GG, Vohr B, Robertson C, Sokol GM, Solimano A, Singer J, Ehrenkranz RA, Singhal N, Wright LL, Van Meurs K, Stork E, Kirpalani H, Peliowski A, Johnson Y; Neonatal Inhaled Nitric Oxide Study Group. Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. J Pediatr. 2007 Mar;150(3):235-40, 240.e1. doi: 10.1016/j.jpeds.2006.11.065. PMID: 17307536; PMCID: PMC1906720.
  3. Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, Verter J, Stoll BJ, Lemons JA, Papile LA, Shankaran S, Donovan EF, Oh W, Ehrenkranz RA, Fanaroff AA. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000 Jan;105(1 Pt 1):14-20. doi: 10.1542/peds.105.1.14. PMID: 10617698.
  4. Lakshminrusimha S. The pulmonary circulation in neonatal respiratory failure. Clin Perinatol. 2012 Sep;39(3):655-83. doi: 10.1016/j.clp.2012.06.006. PMID: 22954275; PMCID: PMC3598629.
  5. Cabral JE, Belik J. Persistent pulmonary hypertension of the newborn: recent advances in pathophysiology and treatment. J Pediatr (Rio J). 2013 May-Jun;89(3):226-42. doi: 10.1016/j.jped.2012.11.009. Epub 2013 Apr 26. PMID: 23684454.
  6. Storme L, Aubry E, Rakza T, Houeijeh A, Debarge V, Tourneux P, Deruelle P, Pennaforte T; French Congenital Diaphragmatic Hernia Study Group. Pathophysiology of persistent pulmonary hypertension of the newborn: impact of the perinatal environment. Arch Cardiovasc Dis. 2013 Mar;106(3):169-77. doi: 10.1016/j.acvd.2012.12.005. Epub 2013 Mar 29. PMID: 23582679.
  7. Mathew B, Lakshminrusimha S. Persistent Pulmonary Hypertension in the Newborn. Children (Basel). 2017 Jul 28;4(8):63. doi: 10.3390/children4080063. PMID: 28788074; PMCID: PMC5575585.
  8. Barrington KJ, Finer N, Pennaforte T, Altit G. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017 Jan 5;1(1):CD000399. doi: 10.1002/14651858.CD000399.pub3. PMID: 28056166; PMCID: PMC6464941.
  9. Shivanna B, Gowda S, Welty SE, Barrington KJ, Pammi M. Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates. Cochrane Database Syst Rev. 2019 Oct 1;10(10):CD012963. doi: 10.1002/14651858.CD012963.pub2. Epub ahead of print. PMID: 31573068; PMCID: PMC6771085.
  10. Perez KM, Laughon M. Sildenafil in Term and Premature Infants: A Systematic Review. Clin Ther. 2015 Nov 1;37(11):2598-2607.e1. doi: 10.1016/j.clinthera.2015.07.019. Epub 2015 Oct 19. PMID: 26490498.
  11. Bassler D, Kreutzer K, McNamara P, Kirpalani H. Milrinone for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD007802. doi: 10.1002/14651858.CD007802.pub2. PMID: 21069698; PMCID: PMC6823268.
  12. Maneenil G, Thatrimontrichai A, Janjindamai W, Dissaneevate S. Effect of bosentan therapy in persistent pulmonary hypertension of the newborn. Pediatr Neonatol. 2018 Feb;59(1):58-64. doi: 10.1016/j.pedneo.2017.02.003. Epub 2017 Jul 11. PMID: 28735030.
  13. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663-5. doi: 10.1038/263663a0. PMID: 802670.
  14. Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, Badesch D, Voelkel NF. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med. 1999 Jun;159(6):1925-32. doi: 10.1164/ajrccm.159.6.9804054. PMID: 10351941.
  15. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992 Jul 9;327(2):70-5. doi: 10.1056/NEJM199207093270202. PMID: 1603138.
  16. Krause W, Krais T. Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man. Eur J Clin Pharmacol. 1986;30(1):61-8. doi: 10.1007/BF00614197. PMID: 2423342.
  17. Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr. 2002 Dec;141(6):830-2. doi: 10.1067/mpd.2002.129849. PMID: 12461501.
  18. Ehlen M, Wiebe B. Iloprost in persistent pulmonary hypertension of the newborn. Cardiol Young. 2003 Aug;13(4):361-3. doi: 10.1017/s1047951103000726. PMID: 14694957.
  19. Concheiro Guisán A, Sousa Rouco C, Suárez Traba B, Paradela Carreira A, Ocampo Cardalda S, Antelo Cortizas J. Iloprost inhalado: una alternativa terapéutica para la hipertensión pulmonar persistente del recién nacido [Inhaled iloprost: a therapeutic alternative for persistent pulmonary hypertension of the newborn]. An Pediatr (Barc). 2005 Aug;63(2):175-6. Spanish. doi: 10.1157/13077463. PMID: 16045880.
  20. De Luca D, Zecca E, Piastra M, Romagnoli C. Iloprost as ’rescue’ therapy for pulmonary hypertension of the neonate. Paediatr Anaesth. 2007 Apr;17(4):394-5. doi: 10.1111/j.1460-9592.2006.02104.x. PMID: 17359413.
  21. Chotigeat U, Jaratwashirakul S. Inhaled iloprost for severe persistent pulmonary hypertension of the newborn. J Med Assoc Thai. 2007 Jan;90(1):167-70. PMID: 17621749.
  22. Limsuwan A, Wanitkul S, Khosithset A, Attanavanich S, Samankatiwat P. Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease. Int J Cardiol. 2008 Oct 13;129(3):333-8. doi: 10.1016/j.ijcard.2007.08.084. Epub 2007 Dec 21. PMID: 18096256.
  23. Eifinger F, Sreeram N, Mehler K, Huenseler C, Kribs A, Roth B. Aerosolized iloprost in the treatment of pulmonary hypertension in extremely preterm infants: a pilot study. Klin Padiatr. 2008 Mar-Apr;220(2):66-9. doi: 10.1055/s-2007-984370. Epub 2007 Aug 21. PMID: 17710738.
  24. Han YK, Lee SM, Eun HS, Kim JE, Namgung R, Park MS, et al. The therapeutic effect of inhaled iloprost in newborn infants with severe persistent pulmonary hypertension refractory to inhaled nitric oxide. Korean J Perinatol 2011 Mar;22(1):57-63.
  25. Gokce I, Kahveci H, Turkyilmaz Z, Adakli B, Zeybek C. Inhaled iloprost in the treatment of pulmonary hypertension in very low birth weight infants: a report of two cases. J Pak Med Assoc. 2012 Apr;62(4):388-91. PMID: 22755287.
  26. Avila-Alvarez A, Bravo-Laguna MC, Bronte LD, Del Cerro MJ. Inhaled iloprost as a rescue therapy for transposition of the great arteries with persistent pulmonary hypertension of the newborn. Pediatr Cardiol. 2013;34(8):2027-9. doi: 10.1007/s00246-012-0575-2. Epub 2012 Nov 11. PMID: 23143352.
  27. Kahveci H, Yilmaz O, Avsar UZ, Ciftel M, Kilic O, Laloglu F, Ozturk K. Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn. Pediatr Pulmonol. 2014 Dec;49(12):1205-13. doi: 10.1002/ppul.22985. Epub 2014 Jan 14. PMID: 24420987.
  28. Yilmaz O, Kahveci H, Zeybek C, Ciftel M, Kilic O. Inhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertension. Am J Perinatol. 2014 Apr;31(4):321-6. doi: 10.1055/s-0033-1348949. Epub 2013 Jun 24. PMID: 23797963.
  29. Chotigeat U, Champrasert M, Khorana M, Sangtaweesin V, Kanjanapattanakul W. Iloprost inhalation for the treatment of severe persistent pulmonary hypertension of the newborn, experience at QSNICH. J Med Assoc Thai. 2014 Jun;97 Suppl 6:S89-94. PMID: 25391178.
  30. Dykes JC, Torres M, Alexander PJ. Continuous inhaled iloprost in a neonate with d-transposition of the great arteries and severe pulmonary arterial hypertension. Cardiol Young. 2016 Mar;26(3):571-3. doi: 10.1017/S1047951115001250. Epub 2015 Jul 29. PMID: 26220108.
  31. Unal S, Aktas S, Aksu M, Hirfanoglu IM, Atalay Y, Turkyilmaz C. Iloprost Instillation in Two Neonates with Pulmonary Hypertension. J Coll Physicians Surg Pak. 2017 Apr;27(4):257-259. PMID: 28492159.
  32. Seung Hyun Kim, MD, Hyun Ju Lee, PhD, Nam Su Kim, PhD, and Hyun-Kyung Park, PhD. Inhaled Iloprost as a First-Line Therapy for Persistent Pulmonary Hypertension of the Newborn. Neonatal Med 2019 November;26(4):191-197. https://doi.org/10.5385/nm.2019.26.4.191.
  33. Ewert R, Schäper C, Halank M, Gläser S, Opitz CF. Inhalative iloprost - pharmacology and clinical application. Expert Opin Pharmacother. 2009 Sep;10(13):2195-207. doi: 10.1517/14656560903164228. PMID: 19663611.
  34. Olschewski H, Simonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W; Aerosolized Iloprost Randomized Study Group. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002 Aug 1;347(5):322-9. doi: 10.1056/NEJMoa020204. PMID: 12151469.
  35. Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol. 2008 Jan 15;51(2):161-9. doi: 10.1016/j.jacc.2007.09.031. PMID: 18191742; PMCID: PMC3125969.
  36. Usha Krishnan MD, DM, Erika Berman-Rosenzweig MD, in Kendig’s Disorders of the Respiratory Tract in Children (Ninth Edition), pp 2089, 2019.
  37. Janjindamai W, Thatrimontrichai A, Maneenil G, Chanvitan P, Dissaneevate S. Effectiveness and safety of intravenous iloprost for severe persistent pulmonary hypertension of the newborn. Indian Pediatr. 2013 Oct;50(10):934-8. doi: 10.1007/s13312-013-0263-1. Epub 2013 Apr 5. PMID: 23798625.